Aurora Cannabis Inc vs Cardinal Health Inc — how do they compare? Aurora Cannabis Inc trades at $3.39 (market cap $178.92M), while Cardinal Health Inc trades at $240.39 (market cap $55.55B). The key difference: Cardinal Health Inc is far larger — about 310.5× Aurora Cannabis Inc's market cap, and Cardinal Health Inc pays a 0.86% dividend while Aurora Cannabis Inc pays none. Which is the better fit depends on your goals.
| ACB | CAH | |
|---|---|---|
Market Cap | $178.92M | $55.55B |
Sector | Health | Health |
52-Week High | $6.23 | $240.26 |
52-Week Low | $2.58 | $146.04 |
Enterprise Value | $123.48M | $60.53B |
Dividend Yield | — | 0.86% |
Signals from Pluang's Aura AI — not financial advice
Aurora Cannabis (ACB) trades at $2.99, up 0.34% with a bullish technical signal despite mixed earnings. The company achieved record annual medical cannabis revenue growth of 18% YoY to $288.6 million in FY2026, but faces margin pressure from Canadian reimbursement changes. Recent Q1 2027 earnings beat expectations with $0.04 EPS versus -$0.13 estimate, though revenue declined to $67.6 million. The stock shows strong institutional support with shareholder approval of board measures and EU-GMP certification for international expansion.
ACB presents a high-risk opportunity with significant volatility. While international medical cannabis growth and operational improvements provide upside potential, persistent net losses, negative ROE/ROA, and Canadian market challenges create substantial headwinds. Analyst consensus remains cautious with only 21% buy ratings, reflecting concerns about profitability timeline and competitive pressures in the evolving cannabis sector.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →